
Arix Bioscience
London, England, United KingdomFounded 201531+ employeesARIX
$21.4M raisedIPO· last: post ipo equity (Apr 2018)· 1 rounds
Arix Bioscience is a global venture capital firm that invests in biotechnology firms. It works with exceptional entrepreneurs and provides the capital, expertise, and global networks required to help them turn their ideas into significant new treatments for patients. As a publicly traded company, they can bring this exciting growth phase of the industry to a wider range of investors.